Rex Shunt for Acute Portal Vein Thrombosis After Pediatric Liver Transplantation in Children With Biliary Atresia

Carregando...
Imagem de Miniatura
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
TRANSPLANTATION PROCEEDINGS, v.43, n.1, p.194-195, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background/Purpose. Posttransplantation portal vein thrombosis (PVT) can have severe health consequences, and portal hypertension and other consequences of the long-term privation of portal inflow to the graft may be hazardous, especially in young children. The Rex shunt has been used successfully to treat PVT patients since 1998. In 2007, we started to perform this surgery in patients with idiopathic PVT and late posttransplantation PVT. Herein we have reported our experience with this technique in acute posttransplantation PVT. Methods. Three patients of ages 12, 15, and 18 months underwent cadaveric (n = 1) or living donor (n = 2) orthotopic liver transplantation (OLT). All patients had biliary atresia with portal vein hypoplasia; they developed acute PVT on the first postoperative day. They underwent a mesenteric-portal surgical shunt (Rex shunt) using a left internal jugular vein autograft (n = 2) or cadaveric iliac vein graft (n = 1) on the first postoperative day. Results. The 8-month follow-up has confirmed shunt patency by postoperative Doppler ultrasound. There have been no biliary complications to date. Conclusions. The mesenteric-portal shunt (Rex shunt) using an autograft of the left internal jugular or a cadaveric vein graft should be considered for children with acute PVT after OLT. These children usually have small portal veins; reanastomosis is often unsuccessful. In addition, this technique has the advantage to avoid manipulation of the hepatic hilum and biliary anastomosis. Although this study was based on a limited experience, we concluded that this technique is feasible, with great benefits to and low risks for these patients.
Palavras-chave
Referências
  1. Alberti D, 1998, J PEDIATR SURG, V33, P597
  2. de Goyet JD, 1999, EUR J SURG, V165, P777
  3. deGoyet JD, 1996, TRANSPLANTATION, V62, P71, DOI 10.1097/00007890-199607150-00015
  4. Cheng YF, 2004, CLIN TRANSPLANT, V18, P390, DOI 10.1111/j.1399-0012.2004.00178.x
  5. Gibelli NEM, 2009, TRANSPL P, V41, P955, DOI 10.1016/j.transproceed.2009.01.055
  6. Harihara Y, 1999, TRANSPLANTATION, V68, P1199, DOI 10.1097/00007890-199910270-00022
  7. Marwan IK, 1999, SURGERY, V125, P265, DOI 10.1067/msy.1999.95114
  8. Mitchell A, 2002, TRANSPLANTATION, V73, P1244, DOI 10.1097/00007890-200204270-00009
  9. Shibasaki S, 2010, CLIN TRANSPLANT, V24, P550, DOI 10.1111/j.1399-0012.2009.01123.x